This formula is the Next Big Thing in Hair Loss Treatments for Practices
Quality comes from commitment. AmWiner is committed to abiding by The Drug Quality and Security Act (DQSA) which, is intended to ensure that the highest quality of drugs are produced under cGMP. We not only abide by governing regulations but seek to set new benchmarks for compliance and excellence. Meeting patient needs is at our core. Our good practices protect our clients, our company, and the industry, ensuring that consumers continue to have access to the safe and effective custom products they need. Every product we produce is with our commitment to benefit health and wellbeing.
Formula1: Tacrolimus 0.1%, Minoxidil 7%, Progesterone 0.1%, Tretinoin 0.025% Formula 2: Hair loss- Men, Minoxidil Sulfate 12%, Finasteride 0.1%, Alfatradiol.0.05%,Tacrolimus 0.1%
Through advanced algorithms of AmWiner`s AI PHARMA technology, we analyze every finished product to produce a more accurate certificate of analysis and SDS document and conduct stability product testing, shelf-life testing, and efficacy testing. AmWiner's “AI PHARMA Technology” takes the guesswork out when conducting Quality control testing on liquid and solid oral dosage tablets/capsules, friability tests, tablet disintegration tests, dissolution tests, and moisture content tests. This tool is a power engineer in tablet coating when manufacturing XR or enteric-coated pills as well. It determines the exact percentage of the coating ingredient required and should show the best coating substance suitable for each tablet formula.